Roles for Pkd1l1 in bile duct development
Pkd1l1 在胆管发育中的作用
基本信息
- 批准号:10751883
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Biliary atresia (BA) is the main indication to transplant any solid organ in infants less than 1 year of age and has
eluded major discoveries of etiology and pathophysiology for decades. BA is a neonatal liver disease that is best
characterized by fibroinflammatory obstruction of both intra- and extrahepatic bile ducts. Through exome
sequencing of a subset of BA individuals with heterotaxic (laterality) features (those with the BA Splenic
Malformation syndrome), several participants were identified with biallelic damaging mutations in the ciliary gene
PKD1L1 (Polycystic kidney disease 1 like 1). To explore mechanistic consequences of impaired PKD1L1
signaling in humans, we developed an intrahepatic cholangiocyte-restricted Pkd1l1Fl/Fl;Afp-Cre (LKO) mouse.
Recently published data indicates that the absence of Pkd1l1 in the developing mouse liver leads to early biliary
dysmorphology and enhanced peribiliary fibroinflammation at adult ages, moreso in the setting of distal
obstruction after bile duct ligation (BDL). These histologic features strongly mimic those seen in human BA livers,
offering a novel opportunity to discover specific cellular and molecular insights into BA’s rapid and profound
pathogenesis. There are two paradigms that must be uncovered to provide a more thorough understanding of
Pkd1l1, and thus the molecular pathogenesis of BA. First, the consequences of absent Pkd1l1 in the developing
biliary tree that leads to adulthood biliary fibroinflammation are unknown. Second, the mechanism of Pkd1l1
signaling within cholangiocytes, which when absent contributes to biliary pathology, remains to be elucidated.
The overarching hypothesis in this proposal is that Pkd1l1 is required for proper biliary development
and signaling. This hypothesis will be tested through the following two aims. Aim 1 explores the delineation
and characterization of early bile duct dysmorphology in developing prenatal and early postnatal livers. This aim
will utilize the recently developed Pkd1l1Null/Fl (NullFl) and Pkd1l1Null/Fl;Afp-cre (NullLKO) mouse lines. Aim 2 is
an in vitro set of experiments with isolated cholangiocyte studies to define Pkd1l1-interactors and signaling
consequences, specifically in response to various bile acids, in isolated Pkd1l1Fl/Fl and LKO cholangiocytes.
Taken together, we anticipate that these two aims will discover new cellular and molecular mechanisms of biliary
tract development and signaling. In addition, information stemming from these Pkd1l1-based mouse models will
help provide supportive pre-clinical evidence to address the current paucity of effective medical therapeutics in
BA.
项目摘要
胆道闭锁(BA)是在不到1岁的婴儿中移植任何固体器官的主要指标,并且具有
数十年来,躲避病因和病理生理学的主要发现。 BA是一种最佳的新生儿肝病
其特征在于脑内和外膜外胆管的纤维炎症反对。通过外显子
具有异质性(侧向)特征的BA个体的测序(具有BA脾
畸形综合征),在睫状基因中发现了几名参与者的生物损害突变
PKD1L1(多囊肾脏病1类似1)。探索受损PKD1L1的机械后果
我们在人类中的信号传导,开发了一种e脚内胆管细胞限制的PKD1L1FL/FL; AFP-CRE(LKO)小鼠。
最近发表的数据表明,发育中的小鼠肝脏中缺乏PKD1L1导致早期胆道
成年时代的畸形和增强的周围肌膜炎症,在不同的环境中
胆管连接后的阻塞(BDL)。这些组织学特征非常模仿人类肝中看到的那些组织学特征,
提供了一个新的机会,可以发现特定的细胞和分子见解,以了解BA的快速而深刻
发病。必须发现两个范式,以提供对
PKD1L1,因此Ba的分子发病机理。首先,发育中缺乏PKD1L1的后果
导致成年胆道肌炎症的胆道未知。第二,PKD1L1的机制
胆管细胞内的信号传导,如果没有造成胆道病理的影响,仍有待阐明。
该提议中的总体假设是PKD1L1是适当的胆道开发所必需的
和信号。该假设将通过以下两个目标进行检验。 AIM 1探索描述
以及早期胆管畸形学在发展产后和早期生命中的表征。这个目标
将利用最近开发的PKD1L1NULL/FL(NULLFL)和PKD1L1NULL/FL; AFP-CRE(NULLLKO)小鼠线。 AIM 2是
一组孤立的胆管细胞研究的体外实验,以定义PKD1L1相互作用和信号传导
后果,特别是针对各种胆汁酸的响应,在分离的PKD1L1FL/FL和LKO胆管细胞中的后果。
综上所述,我们预计这两个目标将发现胆道的新细胞和分子机制
道的发展和信号传导。此外,这些基于PKD1L1的鼠标模型的信息将
帮助提供支持性的临床前证据,以解决当前有效医疗疗法的缺乏
BA。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
相似国自然基金
PRDX6-PLIN4通路调控星形胶质细胞脂代谢异常在抑郁症发生中的作用研究
- 批准号:82301707
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
莫氏细胞早期异常活化介导的前下托-齿状回环路构建在癫痫发生中的作用研究
- 批准号:82371458
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
METTL1介导m7G甲基化异常修饰在肺动脉高压内皮细胞糖代谢重编程中的作用及机制研究
- 批准号:82370057
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于脂肪酸代谢介导的神经元-星形胶质细胞偶联异常探讨好忘方抗AD作用机制
- 批准号:82305087
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ZNF683+CD8+组织驻留T细胞致食管肠神经干细胞分化异常在贲门失弛缓症发病中的作用和机制探索
- 批准号:82300614
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
- 批准号:1071463410714634
- 财政年份:2023
- 资助金额:$ 4.77万$ 4.77万
- 项目类别:
Generation and Validation of Disease Models for Port-Wine Birthmarks
葡萄酒胎记疾病模型的生成和验证
- 批准号:1072724610727246
- 财政年份:2023
- 资助金额:$ 4.77万$ 4.77万
- 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:1056455310564553
- 财政年份:2023
- 资助金额:$ 4.77万$ 4.77万
- 项目类别:
A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease
一种与模态无关的效力测定,可实现镰状细胞病的体外和体内基因组编辑治疗
- 批准号:1066869410668694
- 财政年份:2023
- 资助金额:$ 4.77万$ 4.77万
- 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:1068344310683443
- 财政年份:2023
- 资助金额:$ 4.77万$ 4.77万
- 项目类别: